Table 1.
Randomized controlled trials included in systematic review.
| Study | Inclusion | Exclusion | Patient characteristics (N women/N fetuses) | Follow up (months) |
|---|---|---|---|---|
| BEAM Rouse (16) 1997–2004 USA |
|
|
|
24 |
| ACTOMgSO4 Crowther (13) 1996–2000 Australia-New Zealand |
|
|
|
24 |
| PREMAG Marret (15,17) 1997–2003 France |
|
|
|
24 |
| Magpie (14) 1998–2001 International (19 countries) |
|
|
|
18 |
| MagNET (12) Mittendorf 1995–1997 USA |
|
|
Preventive arm:
|
18 |
Estimate – uncertain from published data
wks=weeks, PPROM=preterm premature rupture of membrane, PTL=preterm labor, IUFD=intrauterine fetal demise, HTN=hypertension, MgSO4=magnesium sulfate, C/I=contraindication, CD=cesarean delivery, CCB=calcium channel blockers, NRFHT=non reassuring fetal heart tracing, h=hour